Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context
Piercarla Schinco,1 Dorina Cultrera,2 Federica Valeri,1 Alessandra Borchiellini,1 Michela Mantuano,3 Francesca Gorla,3 Alessia Savarese,3 Cristina Teruzzi3 1Hemostasis and Thrombosis Unit, Molinette Hospital of Turin, 2Department of Hematology, Hemophilia Regional Reference Center, University Hospit...
Saved in:
Main Authors: | Schinco P (Author), Cultrera D (Author), Valeri F (Author), Borchiellini A (Author), Mantuano M (Author), Gorla F (Author), Savarese A (Author), Teruzzi C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eric Adolf von Willebrand
by: N. A. Makatsariya
Published: (2021) -
VON WILLEBRAND DISEASE
by: Valeriu Popescu, et al.
Published: (2009) -
Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
by: Seoin Kim, et al.
Published: (2021) -
The role of von Willebrand factor in hemostasis pathology
by: Yu. N. Avtaeva, et al.
Published: (2023) -
First case series of low dose monthly Emicizumab prophylaxis in von Willebrand disease type III
by: Ganesan Kavitha, et al.
Published: (2022)